Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Rossoff, Jenna  [Clear All Filters]
2016
Badawy SM, Rossoff J, Yallapragada S, Liem RI, Sharathkumar AA. Successful medical management of a neonate with spontaneous splenic rupture and severe hemophilia A. Hematol Oncol Stem Cell Ther. 2016.
2019
Rossoff J, Locke M, Helenowski IB, Batra S, Katz BZ, Hijiya N. Cost analysis of bronchoalveolar lavage and respiratory tract biopsies in the diagnosis and management of suspected invasive fungal infection in children with cancer or who have undergone stem cell transplant. Pediatr Blood Cancer. 2019:e27598.
2020
Heneghan MB, Hussain T, Barrera L, Cai SW, Haugen M, Duff A, Shoop J, Morgan E, Rossoff J, Weinstein J, et al. Applying the COM-B model to patient-reported barriers to medication adherence in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020:e28216.
Brown P, Inaba H, Annesley C, Beck J, Colace S, Dallas M, DeSantes K, Kelly K, Kitko C, Lacayo N, et al. Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(1):81-112.
2021
Rossoff J, Jacobsohn D, Kwon S, Kletzel M, Duerst RE, Tse WT, Schneiderman J, Chaudhury S. Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies. Pediatr Blood Cancer. 2021:e29087.
2022
Chehab L, Doody DR, Esbenshade AJ, Guilcher GMT, Dvorak CC, Fisher BT, Mueller BA, Chow EJ, Rossoff J. A Population-Based Study of the Long-Term Risk of Infections Associated With Hospitalization in Childhood Cancer Survivors. J Clin Oncol. 2022:JCO2200230.
2023
McNerney KO, Hsieh EM, Shalabi H, Epperly R, Wolters PL, Hill JA, Gardner R, Talleur AC, Shah NN, Rossoff J. INSPIRED Symposium Part 3: Prevention and Management of Pediatric CAR T Cell-Associated Emergent Toxicities. Transplant Cell Ther. 2023.
Eylon M, Prabhu S, John S, King MJM, Bhatt D, Curran KJ, Erickson C, Karras NA, Phillips CL, Satwani P, et al. Mediport use as an acceptable standard for CAR T cell infusion. Front Immunol. 2023;14:1239132.
McNerney KO, Moskop A, Winestone LE, Baggott C, Talano J-A, Schiff D, Rossoff J, Modi A, Verneris MR, Laetsch TW, et al. Practice preferences for consolidative HSCT following tisagenlecleucel in children and young adults with B-ALL. Transplant Cell Ther. 2023.
Zhao Z, Patel PA, Slatnick L, Sitthi-Amorn A, Bielamowicz KJ, Nunez FA, Walsh AM, Hess J, Rossoff J, Elgarten C, et al. Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer. J Clin Oncol. 2023:JCO2301814.
Barsan V, Li Y, Prabhu S, Baggott C, Nguyen K, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano J-A, et al. Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns. EClinicalMedicine. 2023;65:102268.